Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Applied Optoelectronics' subsidiary, Global Technology, Inc., entered into a 10-year lease for a 38,311.8 square meter factory building in Ningbo, China. The company intends to make alterations and improvements to the property to accommodate its production requirements. The lease includes a three-month rent-free renovation period and a right of first refusal to purchase the property.
Stockholders of Zoned Properties, Inc. approved the sale of substantially all of the company's assets to BPB Partners, LLC, an entity owned by members of the company's management group. The transaction, structured as a management buy-out (MBO), received both majority and disinterested stockholder approval at a special meeting held on September 11, 2026. Stockholders also approved, on an advisory basis, the compensation arrangements for named executive officers related to the asset sale.
Ares Capital $750M Debt Financing with U.S. Bank Trust Company, National Association
Ares Capital Corporation completed the issuance and sale of $750 million in 6.250% senior unsecured notes due 2033. The company intends to use the net proceeds to repay outstanding indebtedness under its existing credit facilities. The notes were issued under a Seventh Supplemental Indenture with U.S. Bank Trust Company as trustee.
Co-Diagnostics Research Collaboration with ReadyGo Diagnostics Ltd
Co-Diagnostics entered into a material transfer agreement with ReadyGo Diagnostics Ltd to evaluate the compatibility of ReadyGo's sample collection and preparation technologies with the Co-Dx PCR platform. The collaboration involves feasibility studies and compatibility testing to potentially streamline the sample-to-result workflow for decentralized and point-of-care testing. The agreement is preliminary and does not obligate either party to enter into a formal commercial or development arrangement.
Harte Hanks Signs $19.2M M&A Deal with Star Equity Holdings, Inc.
Harte Hanks announced the expiration of the 'Go-Shop Period' under its existing merger agreement with Star Equity Holdings, Inc. During this period, the company solicited 93 third parties and received alternative acquisition proposals, leading to the designation of certain 'Exempted Parties' for further discussion. However, the Board has not yet determined any proposal to be superior and currently reaffirms its recommendation for the Star merger, which includes a $19.2 million cash consideration cap.
Karen A. Dawes notified Repligen Corporation of her retirement from the Board of Directors, effective September 30, 2026. Her departure follows over twenty years of service and the completion of a successful CEO transition. The company stated the retirement is not due to any disagreement regarding operations, policies, or procedures.
Spectral AI filed a formal investor presentation deck detailing its commercialization strategy for the DeepView System following its May 2026 FDA De Novo classification. The presentation highlights the company's $250 million in non-dilutive government funding and its $150 million contracted revenue base with BARDA for burn and trauma center deployments. The company is transitioning from clinical validation to commercial launch in the US, UK, and Australia.
Walker & Dunlop Debt Financing Update with JPMorgan Chase Bank, N.A.
Walker & Dunlop, Inc. and its subsidiary entered into Amendment No. 9 to their Master Repurchase Agreement with JPMorgan Chase Bank, N.A. The amendment extends the termination date of the credit facility to September 9, 2027, and updates fee and pricing terms via a restated side letter.
Aligos Therapeutics entered into a first amendment to its headquarters lease in South San Francisco, extending the term from March 2027 to March 2034. The amendment sets a graduated monthly base rent starting at $4.650 per square foot and includes a ten-month rent abatement period and a one-time termination option in 2031.
Carlyle Credit Income Fund reported its unaudited net asset value (NAV) per common share as of August 31, 2026. The company disclosed that its management's estimated NAV per share was $3.23.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. issued a letter to shareholders of Aurora Cannabis Inc. urging them to accept its acquisition offer, which represents a 45% premium over Aurora's 30-day VWAP. The proposed combination would create a global cannabis leader with operations in 17 countries and approximately $1.5 billion in combined LTM revenue.
SOBR Safe, Inc. received a delisting notice from Nasdaq on September 14, 2026, notifying the company that its common stock will be delisted at the open of trading on September 16, 2026. The company failed to regain compliance with the $1.00 minimum bid price requirement and the minimum stockholders' equity requirement by the September 15, 2026 deadline previously set by the Nasdaq Hearings Panel. The delisting follows a series of cumulative reverse stock splits exceeding a 1-for-250 ratio, which made the company ineligible for standard compliance grace periods.
Federal Home Loan Bank of New York $158M Debt Financing
The Federal Home Loan Bank of New York committed to issue $158 million in consolidated obligation bonds across four tranches with maturities ranging from 2028 to 2036. These debt securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the Bank's operations and lending activities.
Veradigm Inc. filed a formal investor presentation deck in connection with its participation in the 2026 Jefferies Healthcare Services and Technology Conference and the Deutsche Bank 2026 Healthcare Summit. The presentation outlines the company's 'reset, recover, reignite' strategy and provides preliminary 2025 financial expectations as it works toward relisting on a national securities exchange.
Counterparty
Jefferies Healthcare Services and Technology Conference
Federal Home Loan Bank of Boston $100M Debt Financing with Office of Finance
The Federal Home Loan Bank of Boston committed to issuing $100 million in consolidated obligation bonds on September 9, 2026. These bonds carry a fixed interest rate of 4.35% and are scheduled to mature on September 11, 2028. As joint and several obligations of the 11 Federal Home Loan Banks, these debt securities are used to fund the Bank's operations and are sold through the Office of Finance.
Arcadia Biosciences held its 2026 Annual Meeting of Stockholders where shareholders elected Gregory D. Waller as a Class II director and approved the new 2026 Omnibus Equity Incentive Plan. Stockholders also approved a potential reverse stock split at a ratio between 1-for-2 and 1-for-10, to be implemented at the Board's discretion before June 30, 2027, and ratified executive compensation.
Rithm Perpetual Life Residential Trust Business Update
Rithm Perpetual Life Residential Trust reported its Net Asset Value (NAV) per share as of August 31, 2026, for its Class J and Class E common shares. The total NAV was approximately $161 million, with Class J shares valued at $20.1448 and Class E shares at $20.3053. The trust's portfolio primarily consists of residential transition and mortgage loans valued at approximately $672.7 million, offset by $523.5 million in secured financings.
Aerkomm Inc. announced that Jeff T.C. Hsu resigned from the Board of Directors effective May 31, 2025. To fill the vacancy, the Board appointed Tayi Shen, the company's current Vice President of Business Development, as a director effective September 14, 2026. Mr. Shen brings extensive experience in strategic business development and resilient communications within the defense sector.
Greene County Bancorp, Inc. redeemed $10.0 million in aggregate principal amount of its 3.00% Fixed-to-Floating Rate Subordinated Notes due 2031. The redemption was executed at 100% of the principal amount using cash on hand, leaving $20.0 million in principal amount of the notes outstanding.
Federal Home Loan Bank of Indianapolis $262M Debt Financing with Federal Home Loan Banks
The Federal Home Loan Bank of Indianapolis has become the primary obligor for several consolidated obligation bonds issued by the FHLBanks. The total par value of the bonds committed between September 9 and September 11, 2026, is $262.5 million, with maturities ranging from 2028 to 2051.
Federal Home Loan Bank of Topeka $10M Debt Financing with Office of Finance
The Federal Home Loan Bank of Topeka committed to issue $10 million in consolidated obligation bonds maturing in September 2036. These bonds are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the bank's operations in the capital markets.
Federal Home Loan Bank of Atlanta $365M Debt Financing with Office of Finance
The Federal Home Loan Bank of Atlanta committed to issue $365 million in consolidated obligation bonds and notes across three tranches between September 9 and September 10, 2026. These obligations include a $15 million fixed-rate bond maturing in 2036 and two variable-rate floaters totaling $350 million maturing in late 2026 and early 2027. These securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the Bank's operations.
Jaguar Health entered into exchange agreements to settle outstanding obligations through the issuance of common stock. The company issued 557,377 shares to Lincoln Alternative Strategies LLC to cancel a $175,016.36 promissory note and issued additional shares to Streeterville Capital, LLC in exchange for shares of Series Q Perpetual Preferred Stock.
Tyler Technologies entered into a Rule 10b5-1 trading plan to repurchase up to $260.0 million of its common stock between September 16 and October 29, 2026. This plan is part of a larger $1.5 billion repurchase authorization approved by the Board in July 2026, of which $1.416 billion remains available. The repurchases will be funded through existing cash balances and the company's credit facility.
Federal Home Loan Bank of San Francisco $96M Debt Financing with Office of Finance
The Federal Home Loan Bank of San Francisco committed to issuing $96 million in consolidated obligation bonds across two tranches. The issuance includes $86 million in non-callable fixed-rate bonds maturing in 2028 and $10 million in optional principal redemption bonds maturing in 2031.
AB Private Credit Investors Corp held its 2026 Annual Meeting of Stockholders where shareholders re-elected J. Brent Humphries and Terry Sebastian as Class I directors for three-year terms. Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor and approved a new investment advisory agreement with AB Private Credit Investors LLC.
Tri-State Generation & Transmission Association Leadership Change
Tri-State Generation and Transmission Association reported the unexpected passing of Director Lucas Bear and the departure of Director Robert Brockman from its Board of Directors. Mr. Brockman became ineligible to serve on the Tri-State board after stepping down from the board of Wheatland Rural Electric Association. Successors for both board seats have not yet been identified by their respective member districts.
Federal Home Loan Bank of Cincinnati $112M Debt Financing with Office of Finance
The Federal Home Loan Bank of Cincinnati committed to issue $112.5 million in Consolidated Bonds across multiple tranches with maturities ranging from 2028 to 2046. These debt securities are joint and several obligations of the 11 Federal Home Loan Banks and are used to fund the bank's operations in the capital markets.
NexPoint Capital, Inc. filed an 8-K under Item 8.01 (Other Events). For Business Development Companies (BDCs) and non-traded funds, this item is typically used to provide routine operational updates such as Net Asset Value (NAV) per share or portfolio composition updates.
Abeona Therapeutics Inc. filed an updated investor presentation for its appearance at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The presentation provides a strategic update on the company's clinical pipeline and corporate milestones to the investment community.